Come up with a name for your new list and we'll add to it:
BeiGene raised a round of funding on , . Investors include
WuXi Healthcare Ventures.
BeiGene (百济神州) is a Chinese oncology R&D company focused on discovering, developing and commercializing targeted and immune-oncology therapeutics through a novel translational research platfor…